Diagnostic value of serum ghrelin levels in prostate cancer

Urologia Internationalis

Volumn 80, Issue 3, 2008, Pages 245-248

  Mungan, N Aydin ^a   Eminferzane, Sasan ^a   Mungan, A Gorkem ^a   Yesilli, Cetin ^a   Seckiner, Ilker ^a   Can, Murat ^a   Ayoglu, Ferruh ^a   Akduman, Bulent ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Diagnosis; Ghrelin; Prostate cancer

Indexed keywords

GHRELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER PATIENT; CELL PROLIFERATION; DIAGNOSTIC VALUE; GLEASON SCORE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; STATISTICAL SIGNIFICANCE;

AGED; GHRELIN; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 43749123698     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127334     Document Type: Article

References (13)

1. Jeffery PL, Herington AC, Chophin LK: The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev 2003;14:113-122.
2. Jeffery PL, Herington AC, Chopin LK: Expression and action of the growth hormone-releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002;172:7-11.
3. Cassoni P, Ghe C, Marrocco T, Tabara E, Allia E, Catapano F: Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur J Endocrinol 2004;150:173-184.
4. Hosoda H: Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clin Chem 2004;50:1077-1080.
5. Kolle S, Sinowatz F, Boie G, Temmim-Baker L, Lincoln D: Expression of growth hormone receptor in human prostatic carcinoma and hyperplasia. Int J Oncol 1999;14:911-916.
6. Howard A, Feighner S, Cully D, Arena JP, Liberator PA, Rosenblum CI, van der Ploeg LH: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;12:135-145.
7. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GSH-R, in humans. J Clin Endocrinol Metab 2002;87:2988-2991.
8. Chan JM, Stampher MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P: Plasma IGF-I and prostate cancer risk: a prospective study. Science 1998;279:563-566.
9. Clig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair, Zhang J: Regulations of prostatic growth and function by peptide growth factors. Prostate 1996;392-405.
10. Holly JMP, Gunnell DJ, Davey Smith G: Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999;162:321-330.
11. Tena-Sempere M, Barreiro ML, Gonzales LC, Gaytan F, Zhang FP, Caminos JE: Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717-725.
12. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK: Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 2005;11:8295-8303.
13. Sattler HP, Lensch R, Rohde V: Novel amplication unit at chromosome 3q25-q27 in human prostate cancer. Prostate 2000;45:207-215.